About Perseo pharma

Perseo pharma is a start-up company located in Basel, Switzerland. It is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Muttenz (Baselland), where our lab activities are hosted.

The technology was invented by Prof. Dr. Patrick Shahgaldian (FHNW), who acts as CSO of the company.

The Team

Dr. Yves Dudal
CEO

Biotech engineer by training (National Institute for Applied Sciences, INSA Toulouse, France) and received his PhD in chemical engineering from Polytechnique Montréal, Canada in 2000. Yves has worked 8 years as academic researcher in Montpellier, France, leading to the foundation of his first start-up company in 2010, which was taken over by a european group in 2015. Yves was since the foundation the CEO of INOFEA until he moved to the CEO position of Perseo. He continues supporting INOFEA as Lead Director.

Dr. Emilie Laprévotte
CDO

Emilie Laprévotte has a PhD in biology, with a specialization in oncology, from Paul Sabatier University (Toulouse, France). During her PhD, she developed, in collaboration with Roche Glycart AG, a new combination therapy using an antibody with a human cytokine for the treatment of haematological malignancies. Then she joined OREGA Biotech (Montpellier, France) as project manager where she established the preclinical proof of concept of antibodies targeting the tumor in solid cancers. In 2017, she joined INOFEA AG (Basel, Switzerland), where she established the early proof of concept of enzzen®-therapeutic enzymes. Emilie is now Chief Development Officer at Perseo pharma.

Prof. Dr. Patrick Shahgaldian
CSO

PhD in chemistry from Université Claude Bernard in Lyon, Patrick is now full Professor at the University of Applied Sciences (FHNW) near Basel, where he leads the Molecular Nanotechnology group. He is the main inventor of the enzzen® platform technology and a co-founder of both INOFEA and Perseo pharma. Patrick is the author of more than 90 peer-reviewed publications and of a dozen of patents. His research is well funded through participation in EU- and Swiss-funded projects (H2020, Innosuisse, SNF, etc.). Patrick acts as Chief Scientific Officer for the company.

The Board of Directors

Dr. Yves Dudal, CEO

Biotech engineer by training (National Institute for Applied Sciences, INSA Toulouse, France) and received his PhD in chemical engineering from Polytechnique Montréal, Canada in 2000. Yves has worked 8 years as academic researcher in Montpellier, France, leading to the foundation of his first start-up company in 2010, which was taken over by a european group in 2015. Yves was since the foundation the CEO of INOFEA until he moved to the CEO position of Perseo. He continues supporting INOFEA as Lead Director.

Dr. Werner M. Enz

Chief Executive Officer of EVA, the Basel Life Science start-up agency, and also of the Basel Inkubator, a mandate from the University of Basel and the Fachhochschule Nordwestschweiz (FHNW).
He held various senior executive positions with Roche in Basel, Canada and Germany, including running Roches largest business unit in oncology, immunology and transplant medicine. After a merger project with Rhône Poulenc Rorer (today Sanofi) in Sweden, he worked for Abbott as Commercial Director Europe in the USA and Divisional Head Hospital business in Switzerland.
Dr. Enz also worked for a number of innovative startups and mid-sized B2B technology companies in life science, leading late stage clinical and business development as well as commercial operations, including as country manager and CEO.
He holds a Doctorate in Medicine from the University of Bern, Switzerland, and an MBA from Edinburgh Business School, Scotland, UK.

Dr. Martin Riediker

  • Education in Chemistry at the ETHZ and Princeton University/USA
  • Business und General Management Education at Harvard University/USA
  • 30 years’ experience in the chemical industry
  • Member of the Boards of Plaxica (Bio-based Chemicals), Polymetrix (PET), Micromacinazione (Pharma), INOFEA (Biocatalysis)
  • Member of the Commission for Education and Research of economiesuisse
  • Member of the SCCER Steering Committee
  • President of the Steering Committee of the National Research Program 66: Resource Wood
  • President Engineering Sciences of the Commission for Technology and Innovation
  • Born in Canton Zürich, married, 3 children, now living in Canton Baselland

Stéphane Rousset

  • Business Angel, mentor, advisor, and Board member.
  • He focuses on Swiss technology startups. His corporate career was in the Information and Communications Technology industry.
  • He was a general manager with focus on go-to-market and sales. He held C-level positions at Fujitsu and Oracle, after various leadership positions at Digital Equipment, AT&T, and Global One.
  • He is an alumnus of EPFL, the University of California at Berkeley, and INSEAD.